PMID- 8371029 OWN - NLM STAT- MEDLINE DCOM- 19931014 LR - 20081121 IS - 0148-916X (Print) IS - 0148-916X (Linking) VI - 61 IP - 2 DP - 1993 Jun TI - Development of giant reaction in response to PPD skin test in lepromatous leprosy patients. PG - 205-13 AB - The present study analyzes some clinical and immunological aspects of the giant reaction (GR) in lepromatous leprosy. Sixteen out of a total of 147 (10.9%) lepromatous patients developed the clinical features of GR upon the intradermal administration of PPD; most (14 of 16) GRs occurred in bacteriologically positive cases. GR precipitated an episode of erythema nodosum leprosum (ENL) in three patients. In addition, patients with GR showed enhanced in vitro response to PPD, by the lymphoproliferation test and interferon-gamma assay, as compared to either PPD-negative individuals or PPD-positive patients without GR. Therefore, cell-mediated-immune response to mycobacterial antigens is present in lepromatous patients with GR. It is suggested that the exacerbated in vivo response to PPD in lepromatous leprosy is the result of an increased immunoreactivity to the antigen, which well may be associated with the local and/or systemic release of cytokines [tumor necrosis factor-alpha (TNF alpha) and interferon-gamma (IFN gamma)] by the inflammatory cells. These episodes may, in fact, play an important role in determining the development of disabilities and reactional states, thereby interfering with the prognosis of leprosy disease. FAU - Sampaio, E P AU - Sampaio EP AD - Leprosy Unit, Oswaldo Cruz Foundation, Manguinhos, Rio de Janeiro, Brazil. FAU - Duppre, N C AU - Duppre NC FAU - Nery, J A AU - Nery JA FAU - Moreira, A L AU - Moreira AL FAU - Sarno, E N AU - Sarno EN LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Int J Lepr Other Mycobact Dis JT - International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association JID - 8505819 RN - 0 (Antigens, Bacterial) RN - 0 (Tuberculin) RN - 0 (Tumor Necrosis Factor-alpha) RN - 82115-62-6 (Interferon-gamma) SB - IM MH - Adolescent MH - Adult MH - Aged MH - Antigens, Bacterial/immunology MH - Cells, Cultured MH - Drug Eruptions/*etiology MH - Erythema/*etiology/immunology MH - Female MH - Humans MH - Interferon-gamma/immunology MH - Leprosy, Lepromatous/*immunology MH - Lymphocyte Activation MH - Male MH - Middle Aged MH - Monocytes/immunology MH - Mycobacterium leprae/immunology MH - Tuberculin/*adverse effects MH - Tuberculin Test MH - Tuberculosis/*diagnosis/immunology MH - Tumor Necrosis Factor-alpha/immunology EDAT- 1993/06/01 00:00 MHDA- 1993/06/01 00:01 CRDT- 1993/06/01 00:00 PHST- 1993/06/01 00:00 [pubmed] PHST- 1993/06/01 00:01 [medline] PHST- 1993/06/01 00:00 [entrez] PST - ppublish SO - Int J Lepr Other Mycobact Dis. 1993 Jun;61(2):205-13.